» Articles » PMID: 39329947

Brain Ischemic Tolerance Triggered by Preconditioning Involves Modulation of Tumor Necrosis Factor-α-Stimulated Gene 6 (TSG-6) in Mice Subjected to Transient Middle Cerebral Artery Occlusion

Overview
Publisher MDPI
Specialty Molecular Biology
Date 2024 Sep 27
PMID 39329947
Authors
Affiliations
Soon will be listed here.
Abstract

Ischemic preconditioning (PC) induced by a sub-lethal cerebral insult triggers brain tolerance against a subsequent severe injury through diverse mechanisms, including the modulation of the immune system. Tumor necrosis factor (TNF)-α-stimulated gene 6 (TSG-6), a hyaluronate (HA)-binding protein, has recently been involved in the regulation of the neuroimmune response following ischemic stroke. Thus, we aimed at assessing whether the neuroprotective effects of ischemic PC involve the modulation of TSG-6 in a murine model of transient middle cerebral artery occlusion (MCAo). The expression of TSG-6 was significantly elevated in the ischemic cortex of mice subjected to 1 h MCAo followed by 24 h reperfusion, while this effect was further potentiated ( < 0.05 vs. MCAo) by pre-exposure to ischemic PC (i.e., 15 min MCAo) 72 h before. By immunofluorescence analysis, we detected TSG-6 expression mainly in astrocytes and myeloid cells populating the lesioned cerebral cortex, with a more intense signal in tissue from mice pre-exposed to ischemic PC. By contrast, levels of TSG-6 were reduced after 24 h of reperfusion in plasma ( < 0.05 vs. SHAM), but were dramatically elevated when severe ischemia (1 h MCAo) was preceded by ischemic PC ( < 0.001 vs. MCAo) that also resulted in significant neuroprotection. In conclusion, our data demonstrate that neuroprotection exerted by ischemic PC is associated with the elevation of TSG-6 protein levels both in the brain and in plasma, further underscoring the beneficial effects of this endogenous modulator of the immune system.

Citing Articles

Exploring the Frontiers of Neuroinflammation: New Horizons in Research and Treatment.

Rigillo G, Alboni S Curr Issues Mol Biol. 2024; 46(10):11665-11667.

PMID: 39451572 PMC: 11506371. DOI: 10.3390/cimb46100692.

References
1.
McDonough A, Noor S, Lee R, Dodge 3rd R, Strosnider J, Shen J . Ischemic preconditioning induces cortical microglial proliferation and a transcriptomic program of robust cell cycle activation. Glia. 2019; 68(1):76-94. PMC: 8995040. DOI: 10.1002/glia.23701. View

2.
Bogdani M, Johnson P, Potter-Perigo S, Nagy N, Day A, Bollyky P . Hyaluronan and hyaluronan-binding proteins accumulate in both human type 1 diabetic islets and lymphoid tissues and associate with inflammatory cells in insulitis. Diabetes. 2014; 63(8):2727-43. PMC: 4113060. DOI: 10.2337/db13-1658. View

3.
Kirino T . Ischemic tolerance. J Cereb Blood Flow Metab. 2002; 22(11):1283-96. DOI: 10.1097/01.WCB.0000040942.89393.88. View

4.
La Russa D, Di Santo C, Lizasoain I, Moraga A, Bagetta G, Amantea D . Tumor Necrosis Factor (TNF)-α-Stimulated Gene 6 (TSG-6): A Promising Immunomodulatory Target in Acute Neurodegenerative Diseases. Int J Mol Sci. 2023; 24(2). PMC: 9865344. DOI: 10.3390/ijms24021162. View

5.
Huang W, Chen Q, Dai J, Zhang Y, Yi Y, Wei X . miR-744-5p suppresses tumor proliferation and metastasis by targeting transforming growth factor-beta 1 (TGF-β1) in hepatocellular carcinoma (HCC). J Gastrointest Oncol. 2021; 12(4):1811-1822. PMC: 8421904. DOI: 10.21037/jgo-21-319. View